Skip to main content

Metabolic syndrome and major depression

  • Donatella Marazziti (a1), Grazia Rutigliano (a1), Stefano Baroni (a1), Paola Landi (a1) and Liliana Dell'Osso (a1)...

Major depression is associated with a 4-fold increased risk for premature death, largely accounted by cardiovascular disease (CVD). The relationship between depression and CVD is thought to be mediated by the so-called metabolic syndrome (MeS). Epidemiological studies have consistently demonstrated a co-occurrence of depression with MeS components, ie, visceral obesity, dyslipidemia, insulin resistance, and hypertension. Although the exact mechanisms linking MeS to depression are unclear, different hypotheses have been put forward. On the one hand, MeS could be the hallmark of the unhealthy lifestyle habits of depressed patients. On the other, MeS and depression might share common alterations of the stress system, including the hypothalamus–pituitary–adrenal (HPA) axis, the autonomic nervous system, the immune system, and platelet and endothelial function. Both the conditions induce a low grade chronic inflammatory state that, in turn, leads to increased oxidative and nitrosative (O&NS) damage of neurons, pancreatic cells, and endothelium. Recently, neurobiological research revealed that peripheral hormones, such as leptin and ghrelin, which are classically involved in homeostatic energy balance, may play a role in mood regulation. Metabolic risk should be routinely assessed in depressed patients and taken into account in therapeutic decisions. Alternative targets should be considered for innovative antidepressant agents, including cytokines and their receptors, intracellular inflammatory mediators, glucocorticoids receptors, O&NS pathways, and peripheral mediators.

Corresponding author
*Address for correspondence: Donatella Marazziti, MD, Dipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa, Via Roma 67, 56100 Pisa, Italy. (Email:
Hide All
1.Wulsin, LR, Vaillant, GE, Wells, VE. A systematic review of the mortality of depression. Psychosom Med. 1999; 61(1): 617.
2.Everson-Rose, SA, Meyer, PM, Powell, LH, etal. Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care. 2004; 27(12): 28562862.
3.Osby, U, Brandt, L, Correia, N, Ekbom, A, Sparen, P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001; 58(9): 844850.
4.McIntyre, RS, Alsuwaidan, M, Goldstein, BI, etal. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders. Ann Clin Psychiatry. 2012; 24(1): 6981.
5.Heiskanen, TH, Niskanen, LK, Hintikka, JJ, etal. Metabolic syndrome and depression: a cross-sectional analysis. J Clin Psychiatry. 2006; 67(9): 14221427.
6.Teixeira, PJ, Rocha, FL. The prevalence of metabolic syndrome among psychiatric inpatients in Brazil. Rev Bras Psiquiatr. 2007; 29(4): 330336.
7.Richter, N, Juckel, G, Assion, HJ. Metabolic syndrome: a follow-up study of acute depressive inpatients. Eur Arch Psychiatry Clin Neurosci. 2010; 260(1): 4149.
8.Gil, K, Radzillowicz, P, Zdrojewski, T, etal. Relationship between the prevalence of depressive symptoms and metabolic syndrome: results of the SOPKARD Project. Kardiol Pol. 2006; 64(5): 464469.
9.Diaz-Martinez, L, Serrano, N, Pinzon, J, etal. Lack of association between metabolic syndrome and depressive symptoms in Colombian adults.. Rev Med Chil. 2007; 135(8): 990996.
10.Foley, DL, Morley, KI, Madden, PA, etal. Major depression and the metabolic syndrome. Twin Res Hum Genet. 2010; 13(4): 347358.
11.Muhtz, C, Zyriax, BC, Klahn, T, Windler, E, Otte, C. Depressive symptoms and metabolic risk: effects of cortisol and gender. Psychoneuroendocrinology. 2009; 34(7): 10041011.
12.Vancampfort, D, Vansteelandt, K, Correll, CU, etal. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry. 2013; 170(3): 265274.
13.Czepielewski, L, Daruy Filho, L, Brietzke, E, Grassi-Oliveira, R. Bipolar disorder and metabolic syndrome: a systematic review. Rev Bras Psiquiatr. 2013; 35(1): 8893.
14.Medeiros-Ferreira, L, Obiols, JE, Navarro-Pastor, JB, Zuniga-Lagares, A. Metabolic syndrome and health-related quality of life in patients with schizophrenia. Actas Esp Psiquiatr. 2013; 41(1): 1726.
15.Hung Chi, M, Hua Chang, H, Tzeng, NS, etal. The prevalence of metabolic syndrome in drug-naive bipolar II disorder patients before and after twelve week pharmacological intervention. J Affect Disord. 2013; 146(1): 7983.
16.Bartoli, F, Carra, G, Crocamo, C, Carretta, D, Clerici, M. Bipolar disorder, schizophrenia, and metabolic syndrome. Am J Psychiatry. 2013; 170(8): 927928.
17.Malhotra, N, Kulhara, P, Chakrabarti, S, Grover, S. A prospective, longitudinal study of metabolic syndrome in patients with bipolar disorder and schizophrenia. J Affect Disord. 2013; 150(2): 653658.
18.Suttajit, S, Pilakanta, S. Prevalence of metabolic syndrome and its association with depression in patients with schizophrenia. Neuropsychiatr Dis Treat. 2013; 9: 941946.
19.Pan, A, Keum, N, Okereke, OI, etal. Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care. 2012; 35(5): 11711180.
20.Akbaraly, TN, Kivimaki, M, Brunner, EJ, etal. Association between metabolic syndrome and depressive symptoms in middle-aged adults: results from the Whitehall II study. Diabetes Care. 2009; 32(3): 499504.
21.Akbaraly, TN, Ancelin, ML, Jaussent, I, etal. Metabolic syndrome and onset of depressive symptoms in the elderly: findings from the three-city study. Diabetes Care. 2011; 34(4): 904909.
22.Almeida, OP, Calver, J, Jamrozik, K, Hankey, GJ, Flicker, L. Obesity and metabolic syndrome increase the risk of incident depression in older men: the health in men study. Am J Geriatr Psychiatry. 2009; 17(10): 889898.
23.Koponen, H, Jokelainen, J, Keinanen-Kiukaanniemi, S, Kumpusalo, E, Vanhala, M. Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study. J Clin Psychiatry. 2008; 69(2): 178182.
24.Pulkki-Raback, L, Elovainio, M, Kivimaki, M, etal. Depressive symptoms and the metabolic syndrome in childhood and adulthood: a prospective cohort study. Health Psychol. 2009; 28(1): 108116.
25.Blank, K, Szarek, BL, Goethe, JW. Metabolic abnormalities in adult and geriatric major depression with and without comorbid dementia. J Clin Hypertens (Greenwich). 2010; 12(6): 456461.
26.Gaysina, D, Pierce, M, Richards, M, etal. Association between adolescent emotional problems and metabolic syndrome: the modifying effect of C-reactive protein gene (CRP) polymorphisms. Brain Behav Immun. 2011; 25(4): 750758.
27.Kinder, LS, Carnethon, MR, Palaniappan, LP, King, AC, Fortmann, SP. Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom Med. 2004; 66(3): 316322.
28.Roohafza, H, Sadeghi, M, Talaei, M, Pourmoghaddas, Z, Sarrafzadegan, N. Psychological status and quality of life in relation to the metabolic syndrome: Isfahan Cohort Study. Int J Endocrinol. 2012; 2012: 380902.
29.Takeuchi, T, Nakao, M, Nomura, K, etal. Association of the metabolic syndrome with depression and anxiety in Japanese men: a 1-year cohort study. Diabetes Metab Res Rev. 2009; 25(8): 762767.
30.Viscogliosi, G, Andreozzi, P, Chiriac, IM, etal. Depressive symptoms in older people with metabolic syndrome: is there a relationship with inflammation? Int J Geriatr Psychiatry. 2013; 28(3): 242247.
31.Ahola, AJ, Thorn, LM, Saraheimo, M, Forsblom, C, Groop, PH. Depression is associated with the metabolic syndrome among patients with type 1 diabetes. Ann Med. 2010; 42(7): 495501.
32.Hartley, TA, Knox, SS, Fekedulegn, D, etal. Association between depressive symptoms and metabolic syndrome in police officers: results from two cross-sectional studies. Journal of Environmental and Public Health. 2012; 2012: 861219.
33.Vaccarino, V, McClure, C, Johnson, BD, etal. Depression, the metabolic syndrome and cardiovascular risk. Psychosom Med. 2008; 70(1): 4048.
34.van Reedt Dortland, AK, Giltay, EJ, van Veen, T, etal. Associations between serum lipids and major depressive disorder: results from the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry. 2010; 71(6): 729736.
35.Vogelzangs, N, Suthers, K, Ferrucci, L, etal. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology. 2007; 32(2): 151159.
36.Kahl, KG, Greggersen, W, Schweiger, U, etal. Prevalence of the metabolic syndrome in unipolar major depression. Eur Arch Psychiatry Clin Neurosci. 2012; 262(4): 313320.
37.van Reedt Dortland, AK, Giltay, EJ, van Veen, T, Zitman, FG, Penninx, BW. Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatr Scand. 2010; 122(1): 3039.
38.Tsai, AC, Tsai, HJ. Functional impairment but not metabolic syndrome is associated with depression in older Taiwanese: results from the Social Environment and Biomarkers of Aging Study. J Nutr Health Aging. 2012; 16(5): 492496.
39.Raikkonen, K, Matthews, KA, Kuller, LH. Depressive symptoms and stressful life events predict metabolic syndrome among middle-aged women: a comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions. Diabetes Care. 2007; 30(4): 872877.
40.Goldbacher, EM, Bromberger, J, Matthews, KA. Lifetime history of major depression predicts the development of the metabolic syndrome in middle-aged women. Psychosom Med. 2009; 71(3): 266272.
41.Vanhala, M, Jokelainen, J, Keinanen-Kiukaanniemi, S, Kumpusalo, E, Koponen, H. Depressive symptoms predispose females to metabolic syndrome: a 7-year follow-up study. Acta Psychiatr Scand. 2009; 119(2): 137142.
42.Viinamaki, H, Heiskanen, T, Lehto, SM, etal. Association of depressive symptoms and metabolic syndrome in men. Acta Psychiatr Scand. 2009; 120(1): 2329.
43.Richardson, LP, Davis, R, Poulton, R, etal. A longitudinal evaluation of adolescent depression and adult obesity. Arch Pediatr Adolesc Med. 2003; 157(8): 739745.
44.McIntyre, RS, Rasgon, NL, Kemp, DE, etal. Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap. Curr Diab Rep. 2009; 9(1): 5159.
45.Bonnet, F, Irving, K, Terra, JL, etal. Depressive symptoms are associated with unhealthy lifestyles in hypertensive patients with the metabolic syndrome. J Hypertens. 2005; 23(3): 611617.
46.Bonnet, F, Irving, K, Terra, JL, etal. Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis. 2005; 178(2): 339344.
47.McIntyre, RS, McElroy, SL, Konarski, JZ, etal. Substance use disorders and overweight/obesity in bipolar I disorder: preliminary evidence for competing addictions. J Clin Psychiatry. 2007; 68(9): 13521357.
48.Vogelzangs, N, Beekman, AT, Boelhouwer, IG, etal. Metabolic depression: a chronic depressive subtype? Findings from the InCHIANTI study of older persons. J Clin Psychiatry. 2011; 72(5): 598604.
49.Cizza, G, Ronsaville, DS, Kleitz, H, etal. Clinical subtypes of depression are associated with specific metabolic parameters and circadian endocrine profiles in women: the power study. PLoS One. 2012; 7(1): e28912.
50.Seppala, J, Vanhala, M, Kautiainen, H, etal. Prevalence of metabolic syndrome in subjects with melancholic and non-melancholic depressive symptoms: a Finnish population-based study. J Affect Disord. 2012; 136(3): 543549.
51.Rihmer, Z, Purebl, G, Faludi, G, Halmy, L. Association of obesity and depression. Neuropsychopharmacol Hung. 2008; 10(4): 183189.
52.Luppino, FS, van Reedt Dortland, AK, Wardenaar, KJ, etal. Symptom dimensions of depression and anxiety and the metabolic syndrome. Psychosom Med. 2011; 73(3): 257264.
53.Miettola, J, Niskanen, LK, Viinamaki, H, Kumpusalo, E. Metabolic syndrome is associated with self-perceived depression. Scand J Prim Health Care. 2008; 26(4): 203210.
54.Kamezaki, F, Sonoda, S, Nakata, S, etal. Elevated depressive symptoms are associated with hypertriglyceridemia in Japanese male workers. Intern Med. 2011; 50(21): 24852490.
55.Valtonen, M, Laaksonen, DE, Tolmunen, T, etal. Hopelessness—novel facet of the metabolic syndrome in men. Scand J Public Health. 2008; 36(8): 795802.
56.Maes, M, Smith, R, Christophe, A, etal. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatr Scand. 1997; 95(3): 212221.
57.Sadock, BJ, Sadock, VA. Kaplan & Sadock's Comprehensive Textbook of Psychiatry. Philadelphia: Lippincott Williams & Wilkins Publishers; 2000.
58.Bao, AM, Meynen, G, Swaab, DF. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res Rev. 2008; 57(2): 531553.
59.Gold, PW, Chrousos, GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry. 2002; 7(3): 254275.
60.Björntorp, P. Do stress reactions cause abdominal obesity and comorbidities? Obes Rev. 2001; 2(2): 7386.
61.Björntorp, P, Rosmond, R. Neuroendocrine abnormalities in visceral obesity. Int J Obes Relat Metab Disord. 2000; 24(Suppl 2): S80S85.
62.Björntorp, P, Rosmond, R. The metabolic syndrome—a neuroendocrine disorder? Br J Nutr. 2000; 83(Suppl 1): S49S57.
63.McIntyre, RS, Soczynska, JK, Konarski, JZ, etal. Should depressive syndromes be reclassified as “metabolic syndrome type II”? Ann Clin Psychiatry. 2007; 19(4): 257264.
64.Carney, RM, Freedland, KE, Veith, RC. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med. 2005; 67(Suppl 1): S29S33.
65.Golden, RN, Markey, SP, Risby, ED, etal. Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output. Arch Gen Psychiatry. 1988; 45(2): 150154.
66.Festa, A, D'Agostino, R Jr, Hales, CN, Mykkanen, L, Haffner, SM. Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care. 2000; 23(5): 624628.
67.Panzer, C, Lauer, MS, Brieke, A, Blackstone, E, Hoogwerf, B. Association of fasting plasma glucose with heart rate recovery in healthy adults: a population-based study. Diabetes. 2002; 51(3): 803807.
68.Gans, RO. The metabolic syndrome, depression, and cardiovascular disease: interrelated conditions that share pathophysiologic mechanisms. Med Clin North Am. 2006; 90(4): 573591.
69.Carnethon, MR, Golden, SH, Folsom, AR, Haskell, W, Liao, D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk in Communities study, 1987–1998. Circulation. 2003; 107(17): 21902195.
70.Benthem, L, Keizer, K, Wiegman, CH, etal. Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation. Am J Physiol Endocrinol Metab. 2000; 279(6): E1286E1293.
71.Kreier, F, Yilmaz, A, Kalsbeek, A, etal. Hypothesis: shifting the equilibrium from activity to food leads to autonomic unbalance and the metabolic syndrome. Diabetes. 2003; 52(11): 26522656.
72.Capuron, L, Su, S, Miller, AH, etal. Depressive symptoms and metabolic syndrome: is inflammation the underlying link? Biol Psychiatry. 2008; 64(10): 896900.
73.Maes, M, Berk, M, Goehler, L, etal. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med. 2012; 10: 66.
74.Catena-Dell'Osso, M, Bellantuono, C, Consoli, G, etal. Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development? Curr Med Chem. 2011; 18(2): 245255.
75.Mohamed-Ali, V, Goodrick, S, Rawesh, A, etal. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997; 82(12): 41964200.
76.Yudkin, JS, Stehouwer, CD, Emeis, JJ, Coppack, SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999; 19(4): 972978.
77.Valtonen, MK, Laaksonen, DE, Laukkanen, JA, etal. Low-grade inflammation and depressive symptoms as predictors of abdominal obesity. Scand J Public Health. 2012; 40(7): 674680.
78.Maiese, K, Morhan, SD, Chong, ZZ. Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. Curr Neurovasc Res. 2007; 4(1): 6371.
79.Lutter, M, Elmquist, J. Depression and metabolism: linking changes in leptin and ghrelin to mood. F1000 Biol Rep. 2009; 1: 63.
80.Lu, XY. The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol. 2007; 7(6): 648652.
81.Yamada, N, Katsuura, G, Ochi, Y, etal. Impaired CNS leptin action is implicated in depression associated with obesity. Endocrinology. 2011; 152(7): 26342643.
82.Adamec, R, Burton, P, Blundell, J, Murphy, DL, Holmes, A. Vulnerability to mild predator stress in serotonin transporter knockout mice. Behav Brain Res. 2006; 170(1): 126140.
83.Hommel, JD, Trinko, R, Sears, RM, etal. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron. 2006; 51(6): 801810.
84.Lutter, M, Sakata, I, Osborne-Lawrence, S, etal. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci. 2008; 11(7): 752753.
85.Skibicka, KP, Hansson, C, Egecioglu, E, Dickson, SL. Role of ghrelin in food reward: impact of ghrelin on sucrose self-administration and mesolimbic dopamine and acetylcholine receptor gene expression. Addict Biol. 2012; 17(1): 95107.
86.Bountziouka, V, Polychronopoulos, E, Zeimbekis, A, etal. Long-term fish intake is associated with less severe depressive symptoms among elderly men and women: the MEDIS (MEDiterranean ISlands Elderly) epidemiological study. J Aging Health. 2009; 21(6): 864880.
87.Mamplekou, E, Bountziouka, V, Psaltopoulou, T, etal. Urban environment, physical inactivity and unhealthy dietary habits correlate to depression among elderly living in eastern Mediterranean islands: the MEDIS (MEDiterranean ISlands Elderly) study. J Nutr Health Aging. 2010; 14(6): 449455.
88.Sanchez-Villegas, A, Delgado-Rodriguez, M, Alonso, A, etal. Association of the Mediterranean dietary pattern with the incidence of depression: the Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort. Arch Gen Psychiatry. 2009; 66(10): 10901098.
89.Sanchez-Villegas, A, Bes-Rastrollo, M, Martinez-Gonzalez, MA, Serra-Majem, L. Adherence to a Mediterranean dietary pattern and weight gain in a follow-up study: the SUN cohort. Int J Obes (Lond). 2006; 30(2): 350358.
90.Sanchez-Villegas, A, Henriquez, P, Bes-Rastrollo, M, Doreste, J. Mediterranean diet and depression. Public Health Nutr. 2006; 9(8A): 11041109.
91.Sanchez-Villegas, A, Doreste, J, Schlatter, J, etal. Association between folate, vitamin B(6) and vitamin B(12) intake and depression in the SUN cohort study. J Hum Nutr Diet. 2009; 22(2): 122133.
92.Hibbeln, JR. Fish consumption and major depression. Lancet. 1998; 351(9110): 1213.
93.Kyrozis, A, Psaltopoulou, T, Stathopoulos, P, etal. Dietary lipids and geriatric depression scale score among elders: the EPIC-Greece cohort. J Psychiatr Res. 2009; 43(8): 763769.
94.Uzun, S, Kozumplik, O. Management of side effects of antidepressants—brief review of recommendations from guidelines for treatment of major depressive disorder. Psychiatr Danub. 2009; 21(1): 9194.
95.Kozumplik, O, Uzun, S. Metabolic syndrome in patients with depressive disorder—features of comorbidity. Psychiatr Danub. 2011; 23(1): 8488.
96.Chokka, P, Tancer, M, Yeragani, VK. Metabolic syndrome: relevance to antidepressant treatment. J Psychiatry Neurosci. 2006; 31(6): 414.
97.Mann, JJ. The medical management of depression. N Engl J Med. 2005; 353(17): 18191834.
98.Fava, M. Weight gain and antidepressants. J Clin Psychiatry. 2000; 61(Suppl 11): 3741.
99.McIntyre, RS, Soczynska, JK, Konarski, JZ, Kennedy, SH. The effect of antidepressants on lipid homeostasis: a cardiac safety concern? Expert Opin Drug Saf. 2006; 5(4): 523537.
100.Licht, CM, de Geus, EJ, Seldenrijk, A, etal. Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension. 2009; 53(4): 631638.
101.Mezzacappa, E, Steingard, R, Kindlon, D, Saul, JP, Earls, F. Tricyclic antidepressants and cardiac autonomic control in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1998; 37(1): 5259.
102.Ruetsch, O, Viala, A, Bardou, H, Martin, P, Vacheron, MN. Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management. Encephale. 2005; 31(4 Pt 1): 507516.
103.Gussinyer, S, Garcia-Reyna, NI, Carrascosa, A, etal. Anthropometric, dietetic and psychological changes after application of the “Nin@s en movimiento” program in childhood obesity. Med Clin (Barc). 2008; 131(7): 245249.
104.Dunn, AL, Trivedi, MH, Kampert, JB, Clark, CG, Chambliss, HO. Exercise treatment for depression: efficacy and dose response. Am J Prev Med. 2005; 28(1): 18.
105.Bushe, CJ, Bradley, AJ, Doshi, S, Karagianis, J. Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies. Int J Clin Pract. 2009; 63(12): 17431761.
106.Ehret, M, Goethe, J, Lanosa, M, Coleman, CI. The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis. J Clin Psychiatry. 2010; 71(10): 12861292.
107.Kemp, DE, Ismail-Beigi, F, Ganocy, SJ, etal. Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity. J Affect Disord. 2012; 136(3): 11641173.
108.Kemp, DE, Ismail-Beigi, F, Calabrese, JR. Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome. Am J Psychiatry. 2009; 166(5): 619.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

CNS Spectrums
  • ISSN: 1092-8529
  • EISSN: 2165-6509
  • URL: /core/journals/cns-spectrums
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed